Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Arena Pharmaceuticals, Inc.    ARNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ARENA PHARMACEUTICALS, INC
02/14 ARENA PHARMACEUTICALS : Appoints Three New Members to Board of Directors
02/09 ARENA PHARMACEUTICALS : Announces Three Upcoming Presentations at the 12th Congr..
01/17 ARENA PHARMACEUTICALS : Technical Reports on Biotech Stocks -- ContraVir Pharma,..
01/13 ACTIVE BIOTECH STOCK NEWS : Peregrine Pharmaceuticals (PPHM), Arena Pharmaceutic..
01/05 ARENA PHARMACEUTICALS : sells underperforming weight loss drug Belviq to focus o..
01/04 ARENA PHARMACEUTICALS : Belviq story
01/04 ARENA PHARMACEUTICALS : and Eisai Amend Marketing and Supply Agreement for BELVI..
2016 ARENA PHARMACEUTICALS : Will Obesity Drug Stocks Become Mainstream Again?
2016 ARENA PHARMACEUTICALS : Eisai and Arena Pharmaceuticals Announce Regulatory Appr..
2016 ARENA PHARMACEUTICALS : to Present at the 35th Annual J.P. Morgan Healthcare Con..
2016 ARENA PHARMACEUTICALS : Completes Enrollment in Ralinepag Phase 2 Clinical Trial..
2016 ARENA PHARMACEUTICALS ANNOUNCES FOUR : Crohn's & Colitis Foundation's Clinical a..
2016 ARENA PHARMACEUTICALS : to Present at the 28th Annual Piper Jaffray Healthcare C..
2016 ARENA PHARMACEUTICALS : reports 3Q loss
2016 ARENA PHARMACEUTICALS : Reports Third Quarter 2016 Financial Results and Provide..
More most relevant news
All news about ARENA PHARMACEUTICALS, INC
02/14 ARENA PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)
02/14 ARENA PHARMACEUTICALS : Appoints Three New Members to Board of Directors
02/09 ARENA PHARMACEUTICALS : Announces Three Upcoming Presentations at the 12th Congr..
01/17 ARENA PHARMACEUTICALS : Technical Reports on Biotech Stocks -- ContraVir Pharma,..
01/13 ACTIVE BIOTECH STOCK NEWS : Peregrine Pharmaceuticals (PPHM), Arena Pharmaceutic..
01/12 EISAI : Acquires All Global Development And Marketing Rights For Chronic Weight ..
01/12 ARENA PHARMACEUTICALS : and Eisai Amend Marketing and Supply Agreement for BELVI..
01/06 ARENA PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regul..
01/05 ARENA PHARMACEUTICALS : sells underperforming weight loss drug Belviq to focus o..
01/04 ARENA PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Financia..
More news
Sector news : Biotechnology & Medical Research - NEC
02/22 Genmab and J&J's cancer drug set for blockbuster sales this year
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/16 How Sanofi lost out to J&J in $30 billion battle for Actelion
02/14 Gilead challenges GSK with strong HIV drug data
02/13 TEVA PHARMACEUTICAL INDUSTRIES : seeks CEO with pharma background to lead recove..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
01/13 Arena Pharmaceuticals (ARNA) Presents At 35th Annual J.P. Morgan Healthcare C..
01/12 Arena Pharmaceuticals (ARNA) Presents at 35th Annual J.P. Morgan Healthcare C..
01/06 SNIPPET ROUNDUP : Johnson & Johnson And Shire Make Some Deals, But Disappointmen..
01/05 Arena Turns Page On Belviq - Restructures Deal With Eisai
01/04 Arena bails on selling Belviq, transfers remaining commercialization rights t..
2016 Healthcare bounces back from Trump tantrum
Latest Tweets
02/14Arena Pharmaceuticals : Appoints Three New Members to Board of Directors  
01/25Arena Pharmaceuticals's outperform rating reiterated at FBR & Co.  
01/25Arena Pharmaceuticals downgraded by Zacks Investment Research to sell.  
01/25Get the latest news and updates for $SEP $HLIT $ARNA $ORIT $ENLC automaticall.. 
01/23? TODAY'S UNUSUAL CALL FLOW: $ETSY $CENX $SPG $EXK $RMTI $XON $BKS $RARE $GL..
8
More tweets
Qtime:66
Advertisement
Financials ($)
Sales 2016 52,7 M
EBIT 2016 -70,3 M
Net income 2016 -77,7 M
Debt 2016 74,0 M
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 8,19x
EV / Sales 2017 13,0x
Capitalization 358 M
More Financials
Chart ARENA PHARMACEUTICALS, INC
Duration : Period :
Arena Pharmaceuticals, Inc Technical Analysis Chart | ARNA | US0400471027 | 4-Traders
Full-screen chart
Technical analysis trends ARENA PHARMACEUTI...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 4,50 $
Spread / Average Target 206%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Amit D. Munshi President, Chief Executive Officer & Director
Tina Susan Nova Chairman
Craig M. Audet SVP-Operations & Head-Global Regulatory Affairs
Kevin R. Lind Chief Financial Officer & Executive Vice President
John Adams Head-Scientific Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ARENA PHARMACEUTICALS,..0.00%358
INCYTE CORPORATION21.62%24 852
QUINTILES IMS HOLDINGS..2.72%18 301
CELLTRION, INC.--.--%10 911
LONZA GROUP AG2.67%10 319
SEATTLE GENETICS, INC.19.52%8 939
More Results